ADPT vs BMRN · rev $142.4M vs P/E 40, rev $1.76B
Adaptive Biotechnologies Corp (ADPT) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
ADPT currently screens at market cap $2.69B. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the ADPT and BMRN stock pages for the full models.
Not investment advice.